A company called Elixinol Wellness that makes products from a plant called marijuana had a very good day on Tuesday. Their shares, which are like small pieces of the company you can buy and sell, went up by more than double! This made many people happy who bought them because they sold them for much more money than they paid for them.

Summary:
- Elixinol Wellness is a marijuana product company that had a very good day on Tuesday
- Their shares increased by 110% which means they were worth much more
- This made people who bought their shares happy because they could sell them for a profit Read from source...

The article seems to be written with the intention of promoting marijuana stocks and creating a positive sentiment around them. It does not provide any objective analysis or facts to support its claims. Instead, it uses vague terms like "bullish Tuesday" and "top gainers" without defining what these mean or how they are measured.

Some of the inconsistencies and biases in the article include:
- The use of the term "among top gainers" implies that there were other marijuana stocks that performed well on Tuesday, but no specific names or numbers are given to back this up.
- The mention of Elixinol Wellness' 110% increase in share price does not provide any context or reason for why this happened. Was it due to positive earnings reports? Clinical trials? Mergers and acquisitions? Regulatory changes? The article does not explain any of these factors that could have influenced the stock's performance.
- The inclusion of Item 9 Labs as one of the top gainers is questionable, given that its share price dropped by 40% on Tuesday. How can a company be considered a top gainer when it lost almost half of its value in one day?
- The article does not provide any information about Aurora Cannabis or Cannabix Technologies, which are also mentioned in the headline. What were their stock prices and performance on Tuesday? Why are they relevant to the story?
- The use of phrases like "bullish" and "top gainers" without any supporting evidence or data creates a sense of excitement and optimism around marijuana stocks, which may not be justified by reality. This could lead readers to make uninformed decisions based on emotions rather than facts.

1. Elixinol Wellness (OTC: ELLXF) - buy with a target price of $0.05, 350% potential profit. Elixinol is an Australian-based company that produces and distributes hemp-derived CBD products. The company has seen a significant increase in demand for its products due to the growing legalization of hemp-derive